tiprankstipranks
Trending News
More News >
Nordson Corp (NDSN)
NASDAQ:NDSN

Nordson (NDSN) AI Stock Analysis

Compare
371 Followers

Top Page

NDSN

Nordson

(NASDAQ:NDSN)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 5.2)
Rating:76Outperform
Price Target:
$338.00
▲(16.22% Upside)
Action:ReiteratedDate:02/19/26
Overall score reflects strong underlying financial quality (durable margins and cash generation) and a constructive earnings outlook with raised FY26 guidance. These positives are tempered by expensive valuation and technically overbought momentum, plus elevated leverage versus prior years.
Positive Factors
High and durable margins
Nordson's structural profitability — sustained gross margins in the mid-50s and EBIT margins in the low‑to‑mid 20s — signals durable pricing power and cost control across its precision-equipment businesses. That margin base supports earnings resilience if revenue growth slows.
Strong cash generation and conversion
Robust operating and free cash flow, with FCF nearly matching net income on a TTM basis, provides durable internal funding for capex, dividends, buybacks and M&A. High cash conversion underpins balance sheet resilience and long-term capital allocation flexibility.
Advanced Technology Solutions momentum & backlog
Strong ATS segment growth, driven by electronics/semiconductor demand, and a rising backlog provide structural end‑market exposure to higher‑value systems. This supports above‑market margin expansion and multi‑quarter revenue visibility versus commodity industrial cycles.
Negative Factors
Rising leverage and net debt load
Higher leverage and sizable net debt increase financial risk and reduce flexibility for opportunistic investment or to withstand cyclical downturns. Elevated leverage also raises interest‑cost sensitivity and covenant exposure, making capital allocation choices more constrained over the medium term.
Slowing top-line growth
Decelerating revenue growth makes future earnings more dependent on margin maintenance and cost discipline. With top-line expanding at low single digits, sustainable EPS gains require continued margin expansion or buybacks, which may be harder to achieve during end‑market softness.
Mix, FX and ATS timing create margin and volatility risk
Geographic/product mix shifts and favorable FX that carries lower incremental margins can compress overall profitability. Combined with ATS systems' lumpiness, this reduces earnings predictability and can amplify quarter‑to‑quarter volatility despite healthy underlying demand.

Nordson (NDSN) vs. SPDR S&P 500 ETF (SPY)

Nordson Business Overview & Revenue Model

Company DescriptionNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.
How the Company Makes MoneyNordson generates revenue primarily through the sale of its advanced equipment and systems, which are utilized in a wide range of industrial applications. Key revenue streams include the sale of dispensing equipment, surface treatment solutions, and other manufacturing technologies. The company also earns income from service contracts and aftermarket parts, which provide ongoing support and maintenance for its products. Significant partnerships with leading companies in various industries enhance Nordson's market reach and foster innovation, while its focus on R&D helps in developing new technologies that meet evolving customer needs. Additionally, Nordson's global presence allows it to tap into diverse markets, contributing to its overall revenue growth.

Nordson Key Performance Indicators (KPIs)

Any
Any
Sales by Segment
Sales by Segment
Breaks down revenue generated by each business segment, indicating which areas are driving growth and which may need strategic adjustments.
Chart InsightsNordson's Industrial Precision and Medical & Fluid segments are showing resilience, with the latter experiencing a notable 10% growth, supported by organic sales and successful integration of Atrion Medical. However, the Advanced Technology segment faces challenges, with a 4% sales decline due to weak x-ray systems demand. Despite these mixed results, Nordson's robust cash flow and strategic share repurchases position it well for future growth, as reflected in their optimistic 2026 guidance. The absence of sales in Adhesive Dispensing and Industrial Coating segments remains a concern.
Data provided by:The Fly

Nordson Earnings Call Summary

Earnings Call Date:Feb 18, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 25, 2026
Earnings Call Sentiment Positive
The call conveyed a strong start to fiscal 2026 with record sales, record adjusted EPS and EBITDA, robust ATS momentum, healthy free cash flow and an upward revision to full-year guidance. Offsetting items include margin headwinds from geographic/product mix and FX, a slower start in Medical partly due to weather and a prior divestiture, and inherent lumpiness in ATS system demand. On balance, operational execution, cash generation and raised guidance outweigh the manageable challenges.
Q1-2026 Updates
Positive Updates
Record First Quarter Sales
Q1 sales reached a record $669 million, up 9% year-over-year (prior year $615 million); organic sales up 7% driven by strong demand in Asia.
Robust Advanced Technology Solutions (ATS) Performance
ATS sales of $149 million, a 23% increase year-over-year (21% organic growth); segment EBITDA rose 43% to $33 million and margin improved to 22% driven by double-digit electronics dispense growth and recovering X-ray demand.
Profitability Records and Margin Resilience
Adjusted operating profit increased 10% to $166 million; EBITDA was a Q1 record of $203 million, up 8%, with consolidated EBITDA margin around 30% (in line with prior year). Adjusted EPS was a Q1 record of $2.37, up 15% from $2.06.
Strong Free Cash Flow and Capital Deployment
Free cash flow of $123 million in the quarter with cash conversion at 105% of net income (excluding non-cash gain). Company returned capital via $46 million dividends and $82 million share repurchases, while investing $18 million in capex.
Improved Guidance and Backlog Momentum
Backlog up ~4% year-over-year entering Q2. Q2 sales guidance $710–$740 million and adjusted EPS $2.70–$2.90. Full-year guidance raised to $2.86–$2.98 billion (midpoint +4.5%) and adjusted EPS $11–$11.60 (midpoint +10%).
Balance Sheet Strength and Leverage Management
Cash on hand $120 million, net debt ~$1.9 billion, and leverage ratio 2.1x (consistent with year-end targets). New credit facility provides ~ $800 million available capacity and financial flexibility for strategic M&A.
One-time Non-Cash Investment Gain Recognized Separately
A $22 million pre-tax non-cash mark-to-market gain from a minority investment (post-IPO) was recorded in other income and excluded from adjusted earnings.
Negative Updates
Geographic and Product Mix Pressures on Margins
Sales growth concentrated in Asia, where gross margins are generally lower (notably on system sales), resulting in lower incrementals for the quarter and a 2% decline in IPS EBITDA margin to 34% of sales compared with prior year.
Medical & Fluid Solutions Slow Start and Weather Disruption
MFS sales of $193 million were relatively flat year-over-year; organic sales up 3% but hampered by a ~4% divestiture impact. Severe winter storms late in January temporarily reduced production and deliveries, estimated to have trimmed ~1% from quarterly sales.
Divestiture Impact on Comparables
The prior-quarter divestiture of the medical contract manufacturing business reduced comparable sales by about 4%, affecting year-over-year growth comparisons and segment-level metrics.
Foreign Exchange Incremental Drag
Favorable currency translation added ~4% to top-line and ~6% to IPS sales, but FX uplift carries lower incrementals (company cites a 25%–30% incremental for FX moves), reducing margin leverage in the quarter.
ATS Lumpy Systems Demand and Timing Risk
ATS is system-heavy and thus inherently lumpy; results depend on customer installation timing and can produce quarter-to-quarter variability despite strong underlying demand and backlog.
Company Guidance
Nordson raised its fiscal‑2026 outlook off a strong start — record Q1 sales of $669 million (up 9% YoY, 7% organic), backlog +~4% YoY and $123 million of free cash flow — and now guides Q2 sales of $710–$740 million with Q2 adjusted EPS of $2.70–$2.90; full‑year sales are pegged at $2.86–$2.98 billion (midpoint +4.5%) and full‑year adjusted EPS at $11.00–$11.60 (midpoint +10%), with management still projecting a full‑year effective tax rate at the lower end of the prior 18.5%–19.5% range; the high end of the range assumes continued electronics/ATS momentum plus modest industrial/auto improvement, while the low end reflects potential broader end‑market pullbacks.

Nordson Financial Statement Overview

Summary
High-quality profitability and cash generation (gross margins ~54–56%, EBIT margins low-to-mid 20s; strong TTM operating cash flow and free cash flow close to net income). Offsetting factors are slowing revenue growth and a higher leverage profile versus prior years (debt-to-equity rising into ~0.64–0.79 range), which adds cyclicality risk.
Income Statement
84
Very Positive
NDSN shows consistently strong profitability with solid gross margins (~54–56%) and healthy operating profitability (EBIT margin generally in the low-to-mid 20s). Net margins remain attractive (roughly ~17–20%), and TTM (Trailing-Twelve-Months) net income is solid at ~$523M. The key weakness is growth: revenue has decelerated to low single digits in recent annual periods, which makes earnings quality more dependent on margin discipline than top-line expansion.
Balance Sheet
70
Positive
The balance sheet is generally sound with steady equity and solid returns on equity (mid-teens in recent periods; ~16% in TTM (Trailing-Twelve-Months)). Leverage, however, has risen versus earlier years: debt-to-equity moved from ~0.38–0.44 (2021–2022) to ~0.64–0.79 (2023–TTM), increasing financial risk and reducing flexibility if demand softens.
Cash Flow
78
Positive
Cash generation is strong: TTM (Trailing-Twelve-Months) operating cash flow is ~$700M and free cash flow is ~$646M, with free cash flow close to net income (TTM free cash flow to net income ~0.92), supporting earnings quality. That said, free cash flow growth has been choppy and slightly negative in TTM (Trailing-Twelve-Months), and cash flow coverage of net income varies by year, pointing to some variability in working capital or cash conversion.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue2.85B2.79B2.69B2.63B2.59B2.36B
Gross Profit1.57B1.54B1.49B1.43B1.43B1.32B
EBITDA913.91M874.79M810.58M786.74M771.62M703.55M
Net Income523.20M484.47M467.28M487.49M513.10M454.37M
Balance Sheet
Total Assets5.96B5.92B6.00B5.25B3.82B3.79B
Cash, Cash Equivalents and Short-Term Investments120.39M108.44M115.95M115.68M163.46M299.97M
Total Debt2.14B2.16B2.40B1.96B951.22M1.05B
Total Liabilities2.85B2.87B3.07B2.65B1.53B1.63B
Stockholders Equity3.11B3.04B2.93B2.60B2.29B2.16B
Cash Flow
Free Cash Flow646.31M661.12M491.78M606.70M461.70M507.62M
Operating Cash Flow700.48M719.17M556.19M641.28M513.13M545.93M
Investing Cash Flow-30.09M-26.69M-844.40M-1.44B-222.76M-33.17M
Financing Cash Flow-691.09M-706.43M294.50M750.51M-416.01M-422.91M

Nordson Technical Analysis

Technical Analysis Sentiment
Positive
Last Price290.83
Price Trends
50DMA
267.27
Positive
100DMA
250.05
Positive
200DMA
232.46
Positive
Market Momentum
MACD
7.42
Positive
RSI
59.43
Neutral
STOCH
23.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NDSN, the sentiment is Positive. The current price of 290.83 is above the 20-day moving average (MA) of 288.22, above the 50-day MA of 267.27, and above the 200-day MA of 232.46, indicating a bullish trend. The MACD of 7.42 indicates Positive momentum. The RSI at 59.43 is Neutral, neither overbought nor oversold. The STOCH value of 23.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NDSN.

Nordson Risk Analysis

Nordson disclosed 25 risk factors in its most recent earnings report. Nordson reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Nordson Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
$15.46B30.3119.92%1.32%2.85%3.09%
78
Outperform
$17.81B33.8817.85%0.79%8.01%2.67%
77
Outperform
$15.50B32.4812.35%1.56%7.09%-2.29%
76
Outperform
$16.45B31.8617.47%1.64%3.78%4.85%
65
Neutral
$11.77B32.6517.92%0.49%-0.37%21.77%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
$13.80B88.046.22%5.52%9.03%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NDSN
Nordson
290.83
82.89
39.86%
GNRC
Generac Holdings
236.58
97.44
70.03%
GGG
Graco
92.35
7.65
9.03%
IEX
IDEX
206.18
13.39
6.95%
ITT
ITT
208.86
67.50
47.75%
CR
Crane Company
203.59
41.42
25.54%

Nordson Corporate Events

Business Operations and StrategyFinancial Disclosures
Nordson Posts Record Q1 Results, Raises 2026 Guidance
Positive
Feb 18, 2026

Nordson Corporation reported record first-quarter fiscal 2026 results on February 18, 2026, with sales rising 9% year over year to $669 million, driven by 7% organic growth and favorable currency, and net income climbing to $133 million, or $2.38 per diluted share. Adjusted earnings per share reached a first-quarter record of $2.37, backlog increased about 4%, all segments delivered organic growth led by Advanced Technology Solutions’ 23% sales gain, and management raised both second-quarter and full-year 2026 sales and adjusted earnings guidance, signaling growing confidence in demand, particularly in semiconductor and electronics end markets.

The most recent analyst rating on (NDSN) stock is a Buy with a $312.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Nordson Expands Multicurrency Revolving Credit Facility to 2031
Positive
Feb 2, 2026

On January 30, 2026, Nordson Corporation entered into an amended and restated senior unsecured multicurrency revolving credit agreement, replacing its June 6, 2023 facility and establishing a $1.2 billion revolving credit line maturing on January 30, 2031. The agreement, arranged with Wells Fargo as administrative agent and a syndicate of global lenders, allows borrowings in multiple major currencies, includes sub-facilities for standby letters of credit and swingline loans, and is governed by customary covenants tied to leverage and interest coverage ratios, as well as standard events of default. Interest rates under the facility are indexed to base or benchmark rates such as SOFR, EURIBOR, TIBOR, SORA, SONIA or SARON plus a margin based on Nordson’s leverage or debt rating, with proceeds available for working capital, acquisitions, and general corporate purposes, including refinancing existing debt. At closing, Nordson used part of the new facility to repay and retire $248 million of outstanding term loans under its prior credit arrangement, enhancing its financial flexibility and extending its debt maturity profile.

The most recent analyst rating on (NDSN) stock is a Buy with a $311.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Nordson Reports Record Q4 and Fiscal 2025 Results
Positive
Dec 10, 2025

Nordson Corporation reported record results for the fourth quarter and fiscal year 2025, with sales reaching $752 million in the fourth quarter and $2.8 billion for the full year, marking a 1% and 4% increase respectively over the prior year. The company achieved a 9% increase in adjusted earnings per share for the fourth quarter and a 5% increase for the full year, reflecting strong operational performance despite challenges such as the divestiture of its medical contract manufacturing business. Looking ahead to fiscal 2026, Nordson forecasts sales between $2,830 to $2,950 million and adjusted earnings per share ranging from $10.80 to $11.50, driven by its strategic growth framework and strong backlog.

The most recent analyst rating on (NDSN) stock is a Buy with a $285.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 19, 2026